Journal of Clinical Lipidology
Volume 4, Issue 2 , Pages 83-88, March 2010

When is equal not equal?

  • Allan D. Sniderman, MD

      Affiliations

    • Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Room H7.22, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada
    • Corresponding Author InformationCorresponding author.
  • ,
  • Ken Williams, PhD

      Affiliations

    • Department of Medicine, KenAnCo Biostatistics, University of Texas Health Science Center, San Antonio, TX, USA
  • ,
  • Matthew J. McQueen, MD, PhD

      Affiliations

    • Population Health Research Institute, McMaster University, Hamilton, ON, Canada
  • ,
  • Curt D. Furberg, MD, PhD

      Affiliations

    • Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA

Received 18 December 2009; accepted 24 January 2010. published online 01 February 2010.

Abstract

The meta-analysis of the Emerging Risk Factor Collaboration demonstrated that the hazard ratios (HR) of the major cholesterol markers and the major apolipoproteins for vascular disease did not differ significantly in the studies they examined. Their conclusion was that they were functionally interchangeable. We believe there are important limitations in the execution of this study. Nevertheless, even if their findings are correct for groups, their conclusions do not follow for individuals. Conventionally, the HR expresses the increase in risk per standard deviation change for that parameter in a group. However, the predicted risk of vascular disease from an atherogenic parameter depends on its concentration within the individual. Depending on the composition of the apoB lipoproteins, individuals may have either concordant or discordant levels of cholesterol and apoB. For those who are concordant, the two markers predict equal risk. For those who are discordant, the predicted risks for the individual are different. We demonstrate that substantial discordance in the individual HR of non-high-density lipoprotein cholesterol and apoB is common. The result is that even with identical overall HR, apoB points to higher risk in a substantial number of individuals whereas the converse is the case for non- high-density lipoprotein cholesterol. Because we are concerned with risks in individuals, not groups, this discordance is important to appreciate and analyze. Our objective should be to learn how to combine the information from parameters rather than eliminate them and we need to focus on evaluation of risk in individuals and not just groups.

Keywords: ApoB, Non-HDL C, Hazard ratio, Meta-analysis, Cardiovascular risk

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1933-2874(10)00044-9

doi:10.1016/j.jacl.2010.01.005

Journal of Clinical Lipidology
Volume 4, Issue 2 , Pages 83-88, March 2010